medigraphic.com

2014, Number 2

<< Back Next >>

Rev Cuba Endoc 2014; 25 (2)

Urinary tract infection: prevalence, antimicrobial resistance and associated risk factors in type 2 diabetes mellitus patients

González PAA, Dávila MR, Acevedo GO, Ramírez MME, Gilbaja VS, Valencia GC, Cruz ZL, Iriarte A

Language: Spanish
References: 19
Page: 57-65
PDF size: 117.79 Kb.


ABSTRACT

Objectives: to determine the prevalence of urinary tract infection, antimicrobial resistance and associated risk factors in type 2 diabetes mellitus patients.
Methods: prospective, descriptive and cross-sectional study conducted in 300 patients diagnosed with type 2 diabetes mellitus and selected by non-probabilistic sampling. The identification card was used and the clinical and microbiological diagnosis of urinary tract infection was performed. The statistical analysis used the SPSS statistical program version 17 through the odds ratio, the confidence intervals and the chi square test.
Results: total percentage of urinary tract infection was 17 %, asymptomatic bacteriuria reached 12.5 % and symptomatic 38.4 % (p= 0.000; OR= 4.38; IC 95 % 2.09-8.99). The prevalence of urinary tract infection was 6.5 % for men and 22.8 % for women (p= 0.000; OR= 4.22; IC 95 % 1.78-11.51). Escherichia coli was isolated in 68.6 % of cases, followed by Klebsiella spp. in 13.7 %. Regarding the antimicrobial resistance, E. coli exhibited 74.3 % resistance to ciprofloxacin and 68.6 % to ampicillin.
Conclusions: E. coli and Klebsiella spp. were the preponderant bacteria with high percentages of resistance to ampicillin and to cephalosporin, two of the mostly used antimicrobials to control these processes. Sex was the only risk factor associated to urinary tract infection in the diabetic patient.


REFERENCES

  1. Fünfstück R, Nicolle LE, Hanefeld M, Naber KG. Urinary tract infection in patients with diabetes mellitus. Clin Nephrol. 2012 Jan;77(1):40-8.

  2. Geerlings S, Fonseca V, Castro-Diaz D, List J, Parikh S. Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria. Diabetes Res Clin Pract. 2014 Mar;103(3):373-81.

  3. Dalal SH, Nicolle L, Marrs C, Zhang L, Harding G, Foxman B. Long-Term Escherichia coli Asymptomatic Bacteriuria among Women with Diabetes Mellitus. Clin Infect Dis. 2009 Aug 15;49(4):491-7.

  4. Parasca OM, Gheaţă F, Pânzariu A, Geangalău I, Profire L. Importance of sulfonamide moiety in current and future therapy. Rev Med Chir Soc Med Nat Iasi. 2013 Apr-Jun;117(2):558-64.

  5. Nicolle LE. Urinary tract infection in diabetes. Curr Opin Infect Dis. 2005 Feb;18(1):49-53.

  6. Leal AL, Cortés JA, Arias G, Ovalle MV, Saavedra SY, Buitrago G, et al; GREBO. Emergence of resistance to third generation cephalosporins by Enterobacteriaceae causing community-onset urinary tract infections in hospitals in Colombia. Enferm Infecc Microbiol Clin. 2013 May;31(5):298-303.

  7. Yeshitela B, Gebre-Selassie S, Feleke Y. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital. Addis Ababa, Ethiopia. Ethiop Med J. 2012 Jul;50(3):239-49.

  8. Boroumand MA, Sam L, Abbasi SH, Salarifar M, Kassaian E, Forghani S. Asymptomatic bacteriuria in type 2 Iranian diabetic women: a cross sectional study. BMC Women's Health. 2006;6:4.

  9. Guillausseau PJ, Farah R, Laloi-Michelin M, Tielmans A, Rymer R, Warnet A. Urinary tract infections and diabetes mellitus. Rev Prat. 2003 Oct 31;53(16):1790-6.

  10. Turan H, Serefhanoglu K, Nur Torun A, Kulaksizoglu S, Kulaksizoglu M, Pamuk B, et al. Frequency, Risk Factors, and Responsible Pathogenic Microorganisms of Asymptomatic Bacteriuria in Patients with Type 2 Diabetes Mellitus. Jpn J Infect Dis. 2008;61(3):236-8.

  11. Al-Rubeaan KA, Moharram O, Al-Naqeb D, Hassan A, Rafiullah MR. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J Urol. 2013 Jun;31(3):573-8.

  12. Renko M, Tapanainen P, Tossavainen P, Pokka T, Uhari M. Meta-analysis of the Significance of Asymptomatic Bacteriuria in Diabetes. Diabetes Care. 2011;34(1):230-5.

  13. Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1287-92.

  14. Chávez-Valencia V, Gallegos-Nava S, Arce-Salinas CA. Bacterial drug resistance and etiology of non-complicated urinary tract infections. Gac Med Mex. 2010 Jul- Aug;146(4):269-73.

  15. Gallardo Luna MG, Magaña Aquino M, Andrade Rodríguez HJ, Jiménez de la Torre MJ, Sánchez Álvarez K, Fragoso Morales LE. Resistencia a fármacos empleados en infección de vías urinarias en pacientes de primer contacto en una Unidad de Medicina Familiar del IMSS. Enf Inf Microbiol. 2008;28(1):13-8.

  16. Petrovici CG, Dorobăţ C, Matei M, Teodor A, Luca V, Miftode E. Aspects of the antimicrobial resistance profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients. Rev Med Chir Soc Med Nat Iasi. 2011 Jul- Sep;115(3):769-75.

  17. Karlowsky JA, Lagacé-Wiens PR, Simner PJ, DeCorby MR, Adam HJ, Walkty A, et al. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother. 2011 Jul;55(7):3169-75.

  18. Mandal J, Acharya NS, Buddhapriya D, Parija SC. Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli. Indian J Med Res. 2012;136(5):842-9.

  19. Guía de práctica clínica. Diagnóstico y Tratamiento de la Infección Aguda, no Complicada del Tracto Urinario en la Mujer [página en Internet]; Número de Registro IMSS-077-08, México [citado 2 de agosto de 2013]. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/077_GPC_InfAg nocompdeltractourinariomujer/GPCRAPIDAtractourinario.pdf




2020     |     www.medigraphic.com